Orexigen Therapeutics, Inc. (NASDAQ:OREX) Investor Alert: Lawsuit Alleges Misleading Statements
An investor, who purchased shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX), filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Orexigen Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between March 3, 2015 and March 5, 2015.
View full press release